Netherlands· NL-ec3bbec2d1b2
Schüssler zout Nr. 11 Silicea D12 TS Products
A medicinal product containing silicea trit. d12, registered in Netherlands by TS Products.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- SILICEA Trit. D12
- Manufacturer
- TS Products
- Country
- Netherlands (NL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id110503
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/03d4126d-dfdf-44bf-a587-b2488d32518d GET /v1/drugs/03d4126d-dfdf-44bf-a587-b2488d32518d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVH",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h110503_smpc.pdf",
"strength": null,
"atc_label": null,
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg110503",
"excipients": null,
"substances": [
"SILICEA Trit. D12"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h110503.pdf",
"authorised_at": "2011/09/23",
"procedure_number": null,
"dispensing_status": "Uitsluitend apotheek of drogist",
"registration_number": "110503",
"additional_monitoring": "N"
}See everything about silicea trit. d12.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.